SMSamuel A. Manning

Samuel A. Manning

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Samuel A. Manning has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hippo pathway perturbation disrupts cell fate control in the Drosophila eye

    by Abdul Jabbar Saiful Hilmi, Samuel. A Manning, Lucas. G Dent, Katrina A. Mitchell, Kieran F. Harvey

    During animal development, cells acquire specialised fates in a precise spatiotemporal order, which is essential for producing tissues that function appropriately. Cell fate specification is governed by multiple signalling pathways, as well as mechanical forces, which impact cellular transcription. Two such signalling pathways are the Hippo pathway and EGFR pathway, which both control organ growth and the fate of certain cell types in multiple species. Here, we show that Hippo signalling is essential for the maintenance of the cone and primary pigment cell fates in the developing Drosophila eye. When Hippo signalling is compromised, its nuclear effectors Yorkie and Scalloped drive increased expression of the EGFR pathway transcription repressor Yan, which antagonises the cone and primary pigment cell fates. Thus, in addition to its role as a growth suppressor, Hippo signalling promotes the fate of multiple eye cells by maintaining their responsiveness to inductive cues from the EGFR pathway. AUTHOR SUMMARY: As multicellular organisms grow and develop from a zygote, individual cells become increasingly specialised. Cell fate is specified and maintained by the coordinate action of different signalling pathways, whose activity must be tightly controlled in a spatiotemporal fashion. If this fails, cell fate can be disturbed, which can cause developmental abnormalities, and diseases such as cancers. Here, we describe a new function for the Hippo signalling pathway, which was originally discovered as a regulator of Drosophila tissue growth and subsequently linked to the genesis of multiple human cancers. Hippo signalling is essential for maintaining the fate of two key cell types in the Drosophila eye, primary pigment cells and cone cells. Without Hippo signalling these cells cannot properly respond to signals from another key signalling network, the EGFR pathway. Our discoveries add to a growing literature where the Hippo growth control pathway is repurposed to control cell fate in tissues that have ceased growth.

  • Open Access

    Hippo signaling regulates the nuclear behavior and DNA binding times of YAP and TEAD to control transcription

    by Benjamin Kroeger, Samuel A. Manning, Varshini Mohan, Jieqiong Lou, Guizhi Sun, Sara Lamont, Alex J. McCann, Mathias Francois, Jose M. Polo, Elizabeth Hinde, et al.

    Over the past two decades, genetic and proteomic screens have identified the Hippo pathway as a complex signaling network that controls tissue growth and human cancer. Despite these advances, our understanding of how Hippo signaling regulates transcription is less clear. To address this, we used live microscopy to study the nuclear behavior of the major Hippo pathway transcription effectors, YAP and TEADs. We reveal that TEADs are a major determinant of YAP DNA binding and nuclear mobility, while YAP minorly influences TEADs. YAP and TEAD1 associate with DNA for longer periods in cells with intrinsically low Hippo pathway activity and upon acute Hippo pathway perturbation. TEAD1 binds the genome on a broad range of timescales, and this is extended substantially in nuclear condensates. Last, a cancer-associated YAP fusion protein exhibits substantially different biophysical behavior than either YAP or TEAD1. Thus, we reveal that Hippo signaling regulates transcription, in part, by influencing the DNA binding times of YAP and TEADs.


  • Open Access

    Hippo signalling regulates the nuclear behaviour and DNA dwell times of YAP and TEAD to control transcription

    by Benjamin Kroeger, Samuel A. Manning, Varshini Mohan, Qiji Deng, Jieqiong Lou, Guizhi Sun, Sara Lamont, Alex J. McCann, Mathias Francois, Jose M. Polo, et al.

    Over the past two decades, genetic and proteomic screens have enabled the discovery and elucidation of the Hippo pathway as a complex signalling network that controls tissue growth and cell fate and which is of major importance for human cancers. Despite these advances, our understanding of how Hippo signalling regulates transcription is less clear. To address this, we used live microscopy approaches to study the nuclear behaviour of the major transcription effectors of the human Hippo pathway, YAP and TEADs. Our experiments revealed that TEADs are a major determinant of YAP’s nuclear biophysical behaviour, whilst YAP only has a minor influence on TEAD behaviour. Acute chemical inhibition of Hippo signalling stimulated an increase in the DNA residence time of both YAP and TEAD1. Consistently, YAP and TEAD1 bound DNA for longer periods in cells with high intrinsic YAP/TEAD activity (induced trophoblast stem cells) than in cells with low intrinsic YAP/TEAD activity (induced pluripotent stem cells). TEAD1 bound the genome on a broad range of timescales, and this is extended substantially in nuclear condensates. Finally, single molecule tracking experiments revealed that a fusion protein encoded by a cancer-associated YAP allele exhibits substantially different nuclear biophysical behaviour than either YAP or TEAD1. These live microscopy experiments reveal that Hippo signalling regulates transcription at least in part by influencing the DNA dwell times of both YAP and TEAD.


  • Open Access

    Basal spot junctions of epithelial tissues respond to morphogenetic forces and regulate Hippo signaling

    by Benjamin Kroeger, Samuel A. Manning, Yoshana Fonseka, Viola Oorschot, Simon A. Crawford, Georg Ramm, Kieran F. Harvey

    SUMMARY: Organ size is controlled by numerous factors including mechanical forces, which are mediated in part by the Hippo pathway. In growing Drosophila melanogaster epithelial tissues, cytoskeletal tension influences Hippo signalling by modulating the subcellular localisation of key pathway proteins in different apical domains, namely adherens junctions, the sub-apical region and the medial apical cortex. Here, using both electron and light microscopy, we have discovered the existence of basal spot junctions in D. melanogaster epithelial tissues, and that they respond to morphogenetic forces and also influence Hippo signalling. Like adherens junctions, the Warts kinase is recruited to basal spot junctions via Ajuba and E-cadherin, which prevent Warts activation by segregating it from upstream Hippo pathway proteins. Basal spot junctions are prominent when tissues undergo morphogenesis and are highly sensitive to fluctuations in cytoskeletal tension. Basal spot junctions are distinct from focal adhesions, but the latter profoundly influences the abundance of spot junctions by modulating the basal-medial actomyosin network and tension experienced by spot junctions. Thus, basal spot junctions potentially couple morphogenetic forces to Hippo pathway activity and organ growth.

  • Open Access

    The dPix-Git complex is essential to coordinate epithelial morphogenesis and regulate myosin during Drosophila egg chamber development

    by Lucas G. Dent, Samuel A. Manning, Benjamin Kroeger, Audrey M. Williams, Abdul Jabbar Saiful Hilmi, Luke Crea, Shu Kondo, Sally Horne-Badovinac, Kieran F. Harvey

    How biochemical and mechanical information are integrated during tissue development is a central question in morphogenesis. In many biological systems, the PIX-GIT complex localises to focal adhesions and integrates both physical and chemical information. We used Drosophila melanogaster egg chamber formation to study the function of PIX and GIT orthologues (dPix and Git, respectively), and discovered a central role for this complex in controlling myosin activity and epithelial monolayering. We found that Git’s focal adhesion targeting domain mediates basal localisation of this complex to filament structures and the leading edge of migrating cells. In the absence of dpix and git, tissue disruption is driven by contractile forces, as reduction of myosin activators restores egg production and morphology. Further, dpix and git mutant eggs closely phenocopy defects previously reported in pak mutant epithelia. Together, these results indicate that the dPix-Git complex controls egg chamber morphogenesis by controlling myosin contractility and Pak kinase downstream of focal adhesions. A major challenge in biology is to identify the genes and processes that build tissues of correct shape and function. Recently, transmission of mechanical forces through cell adhesions, and control of cell tension via contractile force-generating proteins, have emerged as fundamental to tissue development. Currently, we do not understand how these separate processes are integrated. We gained new insight into morphogenesis and control of contraction through adhesion-localised proteins, by studying mutants of the dPix-Git focal adhesion complex in Drosophila melanogaster egg chambers, a 3D model of tissue morphogenesis. We found that the dPix-Git complex is essential to maintain cell monolayers, and is a regulator of the contractile force-generating protein, myosin. In the absence of the dPix-Git complex, irregular myosin activation led to tissue disruption, however modest suppression of myosin activators rescued this defect. Remarkably, the dPix-Git complex is essential for egg chamber development, but appears dispensable for other D. melanogaster epithelia, indicating the mechanisms that couple adhesion signalling and cell contractile forces are tissue specific. Our study reveals a key molecular link between cell adhesions and contraction, and the conservation of the dPix-Git module in metazoans suggests this mechanism is likely to be evolutionarily conserved in other tube-like tissues.


  • Dynamic Fluctuations in Subcellular Localization of the Hippo Pathway Effector Yorkie In Vivo

    by Samuel A. Manning, Lucas G. Dent, Shu Kondo, Ziqing W. Zhao, Nicolas Plachta, Kieran F. Harvey


  • Open Access

    A Drosophila RNAi library modulates Hippo pathway-dependent tissue growth

    by Joseph H.A. Vissers, Samuel A. Manning, Aishwarya Kulkarni, Kieran F. Harvey

    Libraries of transgenic Drosophila melanogaster carrying RNA interference (RNAi) constructs have been used extensively to perform large-scale functional genetic screens in vivo. For example, RNAi screens have facilitated the discovery of multiple components of the Hippo pathway, an evolutionarily conserved growth-regulatory network. Here we investigate an important technical limitation with the widely used VDRC KK RNAi collection. We find that approximately 25% of VDRC KK RNAi lines cause false-positive enhancement of the Hippo pathway, owing to ectopic expression of the Tiptop transcription factor. Of relevance to the broader Drosophila community, ectopic tiptop (tio) expression can also cause organ malformations and mask phenotypes such as organ overgrowth. To enhance the use of the VDRC KK RNAi library, we have generated a D. melanogaster strain that will allow researchers to test, in a single cross, whether their genetic screen of interest will be affected by ectopic tio expression.


  • Open Access

    Warts Opens Up for Activation

    by Samuel A. Manning, Kieran F. Harvey


  • Homeodomain-Interacting Protein Kinase Regulates Hippo Pathway-Dependent Tissue Growth

    by Carole L.C. Poon, Xiaomeng Zhang, Jane I. Lin, Samuel A. Manning, Kieran F. Harvey


  • Open Access

    An in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discovery

    by Lee F. Willoughby, Tanja Schlosser, Samuel A. Manning, John P. Parisot, Ian P. Street, Helena E. Richardson, Patrick O. Humbert, Anthony M. Brumby

    Summary: Anti-cancer drug development involves enormous expenditure and risk. Key to the rapid and economic identification of novel, bioavailable anti-tumor chemicals is the use of appropriate in vivo tumor models suitable for large-scale screening. Using a Drosophila Ras-driven tumor model, we demonstrate that tumor overgrowth can be curtailed by feeding larvae chemicals with the in vivo pharmacokinetics essential for drug development and known efficacy against human tumor cells. We then develop an in vivo 96-well plate chemical screening platform to carry out large-scale chemical screening with the tumor model. In a proof-of-principle pilot screen of 2000 compounds we identify the glutamine analog, Acivicin, a chemical with known activity against human tumor cells, as a potent and specific inhibitor of Drosophila tumor formation. RNAi-mediated knockdown of candidate Acivicin target genes implicates an enzyme involved in pyrimidine biosynthesis, CTP synthase, as a possible critical target of Acivicin-mediated inhibition. Thus, the pilot screen has revealed that Drosophila tumors are glutamine-dependent, which is an emerging feature of many human cancers, and has validated the platform as a powerful and economic tool for in vivo chemical screening. The platform can also be adapted for use with other disease models, thus offering wide spread applications in drug development.